EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series

Magesh Kirubakaran J P iD, Pooja Shrivastav, Sangeetha R, Surya Kumar K, Ayumi Saito, Sakthivel T

Case Reports in Dermatological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crdm/9959087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Dermatological Medicine, online erschienen am 29.04.2026. Verfasst von Magesh Kirubakaran J P und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Shalya Tantra, Mahatma Gandhi Ayurveda College & Research Centre, Datta Meghe Institute of Higher Education & Research (Deemed to be Un…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of pyoderma gangrenosum (PG) remains a formidable clinical challenge due to its complex, multipathway immunopathogenesis. Although conventional steroid therapy and advanced biologic agents have improved outcomes, a substantial proportion of patients, particularly those with severe, progressive ulceration, exhibit treatment‐refractory disease, highlighting a critical unmet need for novel strategies capable of network‐level immune modulation. To address this, we designed and implemented a self‐regulating, integrative meta‐therapeutic system centered on a nanostructured, herbo‐metallic core of traditionally processed mercury sulfide (HgS) called Linga Chenduram, a compound characterized by its stable crystalline lattice and a toxicokinetic profile favoring particulate clearance. This system synergistically combines the nanocore with adjunctive phytocompounds ( Allium sativum and Aloe vera ), a transient low‐dose glucocorticoid pulse, and an optimized anti‐inflammatory, antioxidant‐rich physiological milieu delivered within a stress‐free environment. In a cohort of four patients with PG refractory to conventional immunosuppressants, this 30‐day protocol elicited a rapid and profound clinical response. Objective metrics demonstrated a mean ulcer area reduction exceeding 61% by Day 30, progressing to complete and sustained re‐epithelialization in all subjects. This robust cutaneous healing occurred concurrently with the normalization of systemic inflammation (C‐reactive protein) and a significant restoration of functional capacity, evidenced by a mean improvement of 35 points on the Anterior Knee Pain Scale. Critically, clinical remission was maintained throughout a 6‐month surveillance period, establishing a definitive steroid‐sparing effect. We propose this multisystem improvements emerge from rational polypharmacology, wherein the nanoengineered HgS core serves as a pivotal immunomodulatory node, potentially engaging master regulatory pathways like NF‐κB to disrupt dysregulated cytokine circuitry. It transcends conventional combination therapy, introducing a paradigm for managing refractory autoinflammation through integrative systems and compelling a rigorous reappraisal of pharmaceutically refined traditional nanomedicines. This preliminary evidence establishes a compelling rationale for future research to deconstruct the system’s architecture and validate its therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

Linga Chenduramintegrative medicinemercury sulfidenanomedicinepyoderma gangrenosumrefractory diseasesteroid-sparing regimen

Autor:innen und Institutionen

  • Department of Shalya Tantra, Mahatma Gandhi Ayurveda College & Research Centre, Datta Meghe Institute of Higher Education & Research (Deemed to be University), Salod (H), Wardha, India.
  • Department of Shalya Tantra, Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, India.
  • Department of Ayurveda, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya, Kanchipuram, India.
  • Department of Shalakya Tantra, Government Ayurveda Medical College & Hospital, Kottar, Nagercoil, India.
  • The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India, tnmgrmu.ac.in.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA, washington.edu.

ORCID-Profile: Magesh Kirubakaran J P

Zitieren

APA

J P, M. K., Shrivastav, P., R, S., K, S. K., Saito, A., & T, S. (2026). Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series. Case Reports in Dermatological Medicine, 2026(1). https://doi.org/10.1155/crdm/9959087

Vancouver

J P MK, Shrivastav P, R S, K SK, Saito A, T S. Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series. Case Reports in Dermatological Medicine. 2026;2026(1). doi:10.1155/crdm/9959087

BibTeX
@article{JP2026,
  author = {J P, Magesh Kirubakaran and Shrivastav, Pooja and R, Sangeetha and K, Surya Kumar and Saito, Ayumi and T, Sakthivel},
  title = {Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series},
  journal = {Case Reports in Dermatological Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crdm/9959087}
}
Kostenlos starten →